Fidelity Investments
CALC icon

Fidelity Investments’s CalciMedica CALC Stock Holding History

Fidelity Investments’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-536
Closed -$820 – 5401
2025
Q2 		$820 Buy
+536
New +$920 ﹤0.01% 4987
2022
Q3 		– Sell
-57
Closed -$1K – 4886
2022
Q2 		$1K Hold
57
– – ﹤0.01% 4676
2022
Q1 		$1K Sell
57
-1
-2% -$19 ﹤0.01% 4764
2021
Q4 		$1K Buy
58
+57
+5,700% +$2.21K ﹤0.01% 4100
2021
Q3 		$0 Sell
1
-58
-98% -$3.26K ﹤0.01% 4388
2021
Q2 		$4K Sell
59
-1,494
-96% -$98K ﹤0.01% 3757
2021
Q1 		$121K Sell
1,553
-170,041
-99% -$50.9M ﹤0.01% 2898
2020
Q4 		$69.7M Buy
171,594
+58,943
+52% +$17.4M 0.01% 1188
2020
Q3 		$20M Buy
+112,651
New +$23.5M ﹤0.01% 1563

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
SSIM
Sheets Smith Investment Management Houston, Texas $154M AUM 66.97% 1-Year Est. Return

Fidelity Investments's CALC Position: Q3 2025 in Review

Fidelity Investments sold out of CalciMedica (CALC) in Q3 2025, closing a stake of 536 shares — an estimated $820 sold.

Fidelity Investments first reported a position in CALC in Q3 2020 and held it in 9 quarters. The position peaked at $69.7M in Q4 2020. 31 funds tracked by Wall St. Rank hold CALC as of Q3 2025.

  • Fidelity Investments reported no remaining CalciMedica position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 536 CalciMedica shares in Q3 2025, an estimated $820.
  • Fidelity Investments first reported a position in CalciMedica in Q3 2020 and held it in 9 quarters.
  • Fidelity Investments's CalciMedica position peaked at $69.7M in Q4 2020.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.